COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

ADDING CANDLES INC

Fairport, NY · EIN 472009255 · Form 990EZ · FY2024 · NTEE E12 · Health Care · Micro (<$100K) · addingcandles.org
revenue
$43K
expenses
$51K
net assets
$21K
employees
mission · from form 990

To raise funds for brain cancer research

profile · synthesized from sources

Adding Candles Inc. is a volunteer-driven nonprofit founded in 2015 to fund brain cancer research at the Wilmot Cancer Institute of the University of Rochester Medical Center. The organization raises money through grassroots fundraising events, primarily its annual "Adding Candles for a Cure" gala, and has exceeded its initial five-year goal by donating over $500,000 to support clinical trials and innovative research projects aimed at improving treatment and quality of life for brain tumor patients.

named programs · 2 · from sources

What they call their work

Adding Candles for a Cure
Annual fundraising gala event that brings together donors, sponsors, patients, and families to raise money for brain cancer research at Wilmot Cancer Institute.
Luminary Award
Annual recognition presented to individuals or groups who exemplify dedication to brain cancer research and patient support.
activities · 2 groups

What they do

  • Cancer Research Funding 3 activities
    • Advancing research on patient experience and biomarkers in brain tumor care
      Funds and supports research initiatives including a large-scale study on patient and caregiver well-being during treatment, and laboratory research on biomarkers to predict epilepsy development in brain tumor patients.
    • Funding brain cancer research at Wilmot Cancer Institute
      Raises and donates funds specifically for brain cancer research at the Wilmot Cancer Institute of URMC through annual fundraising events, having donated over $500,000 cumulatively, including individual donations of $75,000 in 2016, $100,000 in 2017, and $90,000 in 2018.
    • Supporting clinical trials and novel cancer therapies through funding
      Provides financial support that enables the initiation and conduct of clinical trials for brain tumors, including trials for gliomas and novel therapies such as an FDA-approved drug for glioblastoma and a device for chemotherapy-induced neuropathy.
  • Charity Event Organization 1 activity
    • Hosting annual fundraising gala for brain cancer research
      Organizes and hosts an annual fundraising event titled "Adding Candles for a Cure" to support brain cancer research at Wilmot Cancer Institute.
financials · form 990EZ · fy2024
revenue
Total revenue$43K
Contributions & grants$47K110%
Program service revenue$00%
Investment income$00%
Other revenue$0
expenses
Total expenses$51K
Program expenses
Admin / overhead
Fundraising
Salaries & benefits$0
Grants paid out$50K
balance sheet
Total assets$21K
Cash
Investments
Liabilities
Net assets$21K
3 years on record · 2021–2024 · YoY revenue +344.8%
relationships · 12

Who they work with

  • Dr. Nimish Mohile Government — Advising physician for Adding Candles and Division Chief of Neuro-Oncology at Wilmot Cancer Institute.
  • Dr. Nimish Mohile Partner — Serves as advising physician to Adding Candles and leads neuro-oncology efforts at the University of Rochester.
  • Lois Warlick-Jarvie Partner — Primary contact for volunteer opportunities and group fundraising initiatives.
  • National Cancer Institute Government — Sponsors clinical trials in gliomas conducted by the neuro-oncology program.
  • UR Medicine's Wilmot Cancer Institute Partner — Receives funding and support from Adding Candles for brain cancer research.
  • University of Rochester Brain Tumor Program Partner — Partners with the University of Rochester Brain Tumor Program to conduct research on patient experience during treatment.
  • University of Rochester Medical Center Partner — Collaborates on neuro-oncology research and clinical programs.
  • University of Rochester Medical Center Partner — Hosts the Wilmot Cancer Institute, which receives donations from Adding Candles for brain cancer research.
  • University of Rochester School of Medicine and Dentistry Partner — Collaborates with Adding Candles through its neuro-oncology division for potential clinical trials and research projects.
  • Wilmot Cancer Institute Partner — Collaborates with Wilmot Cancer Institute on brain tumor research focused on patient quality of life.
  • Wilmot Cancer Institute Partner — Receives funding from Adding Candles for brain cancer research.
  • Wilmot Cancer Institute of URMC Partner — Funds brain cancer research at Wilmot Cancer Institute of URMC through annual donations from its signature event.
strategies · 4

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Early Palliative Care Integration
    methodology: early_palliative_care_integration
    By integrating palliative care early in the treatment of glioblastoma, the organization improves quality of life for patients and caregivers, because early support addresses physical, emotional, and psychosocial needs before crises occur.
  • Integrated Multidisciplinary Clinic Model
    methodology: integrated_clinic_model
    By centralizing care for conditions like chemotherapy-induced neuropathy in integrated, multidisciplinary clinics, the organization improves symptom management and patient experience, because coordinated access to diverse specialists reduces fragmentation and accelerates treatment.
  • Multi-Year Funding Commitment Model
    methodology: multi_year_funding_commitment
    By providing sustained, multi-year funding for brain cancer research, the organization enables long-term scientific planning and increases the likelihood of securing larger external grants, because stable funding reduces project risk and supports complex research trajectories.
  • Patient-Centered Outcomes Integration
    methodology: patient_centered_outcomes_research
    By integrating patient-reported outcomes into clinical study design, the organization ensures research addresses real-world patient needs and priorities, because involving patients in shaping research increases its relevance and impact on quality of life.